Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
68,061,605
-
Share change
-
+3,797,369
-
Total reported value
-
$2,763,927,916
-
Put/Call ratio
-
78%
-
Price per share
-
$40.61
-
Number of holders
-
269
-
Value change
-
+$143,728,387
-
Number of buys
-
146
-
Number of sells
-
137
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2023
As of 31 Mar 2023,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,061,605 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Capital World Investors, Champlain Investment Partners, LLC, EMINENCE CAPITAL, LP, BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, Bellevue Group AG, and JANUS HENDERSON GROUP PLC.
This page lists
269
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.